- In July 2024, Alcon Research, LLC. received U.S. FDA approval for its UNIPURE C3F8 Ophthalmic Gas, designed for intraocular injection to manage uncomplicated retinal detachment. The gas is compatible with the company’s UNIFEYE and UNIPEXY Gas Delivery Systems and is expected to become commercially available in 2025
- In June 2024, C3 Med-Tech secured a funding of USD 0.24 million from Industrial Metal Powers India Pvt Ltd. to support the development of AI-powered portable ophthalmic devices. These devices are aimed at telemedicine applications, enhancing real-time diagnostics and preventive eye care to reduce the risk of blindness
- In August 2023, Johnson & Johnson Vision unveiled its Elita laser correction system during its U.S. launch, marking a breakthrough in myopia (short-sightedness) treatment. The system enables a minimally invasive lens removal procedure using laser-assisted technology, offering patients a new alternative in vision correction
- In June 2023, Bausch + Lomb Corporation introduced its INFUSE Multifocal daily disposable contact lenses made from silicone hydrogel (SiHy) material. These lenses are designed to provide long-lasting comfort and hydration, helping users maintain clear and irritation-free vision throughout the day
